WASHINGTON, Sept. 19 /PRNewswire-USNewswire/ -- New data, released
today by the Centers for Disease Control and Prevention (CDC), show
alarmingly low influenza vaccination rates in both adults and children. CDC
joined the National Foundation for Infectious Diseases (NFID) and the
nation's leading health organizations at a national news conference urging
increased efforts for Americans to seek immunization against influenza
throughout the fall and winter.
"We need to re-think the influenza immunization season and encourage
vaccination throughout the fall and winter for anyone wishing to be
protected," said Julie L. Gerberding, MD, MPH, director, CDC. "More doses
are expected this year than in previous seasons and there is ample time to
Dr. Gerberding issued this urgent public health message with leaders
from AARP, the American Academy of Pediatrics (AAP), American Medical
Association (AMA), Centers for Medicare & Medicaid Services (CMS), CDC and
NFID, in partnership with the National Influenza Vaccine Summit, at a news
conference this morning at the National Press Club in Washington, D.C.
Dr. Gerberding also released new CDC vaccination coverage rates for
adults and children, which reinforced the need for ongoing efforts to
improve influenza immunization throughout the entire season. During the
2005-2006 season, only one in five children aged 6-23 months were fully
vaccinated and little more than one in ten children needing two doses
received both doses. Influenza vaccine coverage varied substantially among
states, but no state had more than 40 percent of children fully
In addition, this CDC report, released during NFID's News Conference,
indicates that influenza vaccination coverage in all states during the
2005-2006 influenza season was substantially below the national 60 percent
target for persons aged 18-64 years with high-risk conditions, and the 90
percent target for persons aged 65 years and older.(1)
Annual Severe Disease Burden Reinforces Importance of Vaccination
Influenza is responsible for about 36,000 deaths and more than 200,000
hospitalizations in the U.S. each year (2,3) In addition, the disease
results in more than $87 billion of U.S. economic burden annually (e.g.,
hospitalization costs, missed days of work, lost lives, etc.).(4) Influenza
can be especially severe for those with high-risk conditions (e.g.,
diabetes, heart disease), and recent studies have also found the illness
may trigger up to 92,000 cardiac deaths per year nationwide.(5)
"While we cannot predict influenza virus activity each season, we do
know that annual vaccination will help protect individuals against
influenza and also reduce spread of the virus to others," said Jeanne M.
Santoli, MD, MPH, deputy director of the CDC's Immunization Services
The CDC recommends an annual influenza vaccination for anyone,
including school-aged children, who wishes to reduce their risk for
contracting the illness or spreading the disease to others. Additionally,
vaccination is important for certain populations at increased risk for
severe complications, including children from 6 months up to 5 years of
age, people with chronic medical conditions (e.g., asthma, diabetes, heart
disease, HIV) and pregnant women. Immunization is also recommended for
persons 50 years of age and older, health care professionals and all others
in close contact with high-risk populations, particularly in contact with
children younger than 6 months of age who cannot receive influenza vaccine.
This includes parents, grandparents, siblings and babysitters.
"Not only does annual influenza vaccination help protect yourself, it
also helps create a 'cocoon of protection' for those around you," said
William Schaffner, MD, NFID Vice President. "Vaccination is the best way to
prevent influenza from infecting yourself and others, including family,
friends, schoolchildren and co-workers, and is the right thing to do for
your community this and every influenza season."
Time to "Re-think" the Influenza Season: Use Every Opportunity to
Influenza vaccination should begin when vaccine is available in the
community and continue throughout the entire season. Most people
concentrate on vaccination during the fall and winter months, but
vaccination is beneficial well into the New Year: the virus often continues
to circulate through the spring.
The influenza season can begin as early as October and last as late as
May. Typically, the season peaks in February, leaving many months to seek
immunization. Previous seasons have seen a drop in public demand for
vaccine after Thanksgiving, leaving numerous doses unused and many
"Health care professionals and their patients must work together to
make sure every opportunity to discuss influenza immunization and receive
the vaccine is used," said Ardis D. Hoven, MD, Board of Trustees, American
Medical Association. "There is plenty of time each year to get immunized,
especially since the influenza season usually lasts through the spring."
In addition, health care professionals and other caregivers should seek
influenza vaccine for themselves to protect against illness and to prevent
spreading this severe respiratory disease among patients, especially those
who are immunocompromised.
CMS Efforts to Increase Vaccination Rates
Seniors over 65 years of age are among those at greatest risk of
complications and death due to influenza and pneumococcal disease. To
address this risk, Medicare Part B and Medicaid continue to cover influenza
and pneumococcal vaccines. But not enough Americans seek out this benefit,
according to Kerry Weems, Acting Administrator, CMS.
"Vaccination rates for Medicare recipients are critically low
throughout the country. At least 20 percent of Americans with Medicare
don't get their influenza vaccination," said Weems. "For Americans 65 years
of age and older, the importance of getting vaccinated against influenza
and pneumococcal disease can't be overstated."
Medicare reimbursement will stay at current levels this year for
influenza vaccine ($12.62). Rates for pneumococcal vaccine have increased
by 10 percent ($29.73). Medicare's national average administration fee for
both vaccinations will be $19.60, an increase of 4.2 percent from last
Influenza Prevention Among Americans 50+ Helps Maintain Health and
Well-being for Themselves and Close Contacts
Americans aged 50 years and older are leading fuller, more active lives
while also facing added responsibilities at work and home. In fact, with
people living longer, 71 percent of today's baby boomers have at least one
living parent. Approximately one of every eight are raising a child and
providing financial assistance to a parent, according to the Pew Research
"AARP is committed to educating its 39 million members about the
importance of using preventive measures like getting annual influenza
immunizations to guard against illness," said T. Byron Thames, MD, Board of
Directors, AARP. "Increasing vaccination rates among our members will also
help protect those they care for - their grandchildren and parents who are
more vulnerable to influenza and its complications."
The ongoing challenge of balancing work and family reinforces the role
of ongoing wellness and prevention efforts for those 50+, which includes
annual influenza vaccination. According to the CDC, only 36 percent of
adults 50-64 years of age and about 60 percent of those aged 65 years and
older are vaccinated against influenza each year. There are more than 89
million Americans aged 50+ (the largest target group for influenza
vaccine), and this leaves many unprotected every season. They are also
increasing their chances of passing along the influenza virus to their
older parents, spouses, children, grandchildren, friends and co-workers.
Alarmingly High Number of Children Unvaccinated; Leaving Serious Risk
for Severe Illness, Complications
Rates of influenza infection are the highest among children, yet a
large majority are not vaccinated every year, the most effective way to
prevent illness. For example, only 18 percent of children aged 6-23 months
are vaccinated,(6) and just 30 percent of children with asthma (the most
common chronic health condition in children) are immunized.
"When a child dies because of influenza, the devastating loss is felt
throughout the family and community, including the school and even the
pediatrician's office," said AAP President, Jay Berkelhamer, MD. "Several
thousand more children end up in the hospital. Parents and their children's
health care team must work together to ensure these concerning,
vaccine-preventable tragedies don't happen every year."
The CDC estimates nearly 100 U.S. children younger than 5 years of age
die every year due to influenza and its complications.(1) It is necessary
to use every opportunity during the entire influenza season to administer
influenza vaccination to children and their close contacts.
Antiviral Medications Play Key Role in Treating and Preventing
Prescription antiviral medications play an important role in the
prevention and treatment of influenza. Currently, four antiviral
medications are marketed in the United States. For the 2007-2008 season,
the CDC recommends use of oseltamivir (Tamiflu) or zanamivir (Relenza), for
treatment and prevention of influenza. Neither amantadine nor rimantadine
should be used for the treatment or chemoprophylaxis of influenza, due to
high levels of resistance.(7) Resistance to oseltamivir (Tamiflu) and
zanamivir (Relenza) remains extremely uncommon.(8)
If taken within 12-48 hours of symptom onset, antiviral medications can
reduce the duration and severity of influenza, which is characterized by
fever, aches, chills and tiredness. People who are at high risk of serious
complications from influenza may benefit most from antiviral
Antiviral medication can also be used as a preventive measure for those
who have been exposed to influenza or are at high risk for complications.
Prophylactic use of antivirals can help contain the spread of influenza in
crowded settings like nursing homes, schools, households or the workplace.
Antivirals can also be used in patients who cannot receive influenza
vaccine because of egg allergies.
Hospitalizations due to Pneumonia High Among Adults; Vaccination the
Best Prevention Yet Often Unused
CDC estimates that there were over 40,000 U.S. cases of invasive
pneumococcal disease in 2005, resulting in 4,850 deaths.(9) Caused by a
common bacterium, pneumococcal disease is transmitted most often during the
winter and early spring, when other respiratory infections, like influenza,
are circulating in communities.
Anyone can get pneumococcal disease, but some groups are at increased
risk, including persons aged 65 and older and individuals with weak immune
systems or chronic illnesses. In fact, over half of U.S. cases are among
adults who are recommended to receive vaccination.(10)
"Only about 65 percent of people 65 years of age and older have been
vaccinated against pneumococcal disease. This is concerning since this is
the only available prevention method against this seriously
life-threatening disease," said Robert H. Hopkins, Jr., MD, University of
Arkansas for Medical Sciences. "With an increase in reported antibiotic
resistance to this infection, we urge anyone at risk to talk to their
health care provider about immunization."
About the National Foundation for Infectious Diseases
The National Foundation for Infectious Diseases (NFID) is a non-profit,
tax-exempt (501c3) organization founded in 1973 and dedicated to educating
the public and healthcare professionals about the causes, treatment and
prevention of infectious diseases.
About the National Influenza Vaccine Summit
The National Influenza Vaccine Summit, co-sponsored by CDC and the AMA,
is a group of more than 400 members representing 130 organizations,
including: professional medical and public health organizations, advocacy
groups, pharmacists, vaccine manufacturers and distributors, payers,
representatives from hospitals and long term care facilities, health care
providers and other influenza vaccine stakeholders. The Summit's goal is to
address, discuss and help to resolve influenza vaccine issues and to
increase utilization of vaccine in accordance with the Advisory Committee
on Immunization Practices recommendations.
Editor's note - Additional influenza media resources available via
NFID's Web site, HYPERLINK "http://www.nfid.org/" www.nfid.org.
This news conference is sponsored by the National Foundation for
Infectious Diseases in partnership with the National Influenza Vaccine
Summit and is supported, in part, by the Centers for Disease Control and
Prevention, and through unrestricted educational grants to NFID by the
Centers for Medicare & Medicaid Services, CSL Biotherapies, Flu Vaccine
Business Practices Initiative (c/o HIDA), GlaxoSmithKline, Henry Schein,
Inc., MedImmune Vaccines, Merck and Co., Inc., Novartis Vaccines, Roche,
and sanofi pasteur.
(1) Centers for Disease Control and Prevention. MMWR 2007; 56(37).
(2) Centers for Disease Control and Prevention. Prevention and Control
of Influenza: Recommendations of the Advisory Committee on Immunization
Practices (ACIP). MMWR 2007; 56(Early Release):1-40.
(3) Thompson WW, Shay D, Weintraub E, et al. Influenza-associated
hospitalizations in the United States. JAMA 2001;292:1333-1340.
(4) Molinari N, Ortega-Sanchez I, Messonnier M, et al. The annual
impact of season influenza in the U.S: Measuring disease burden and costs.
(5) Madjid, M, Miller C, Zarubaev V, et al. Influenza epidemics and
acute respiratory disease activity are associated with a surge in
autopsy-confirmed coronary heart disease death: results from 8 years of
autopsies in 34,892 subjects. European Heart Journal Advance Access.
Available online, April 17, 2007.
(6) Centers for Disease Control and Prevention. Childhood influenza
vaccination coverage. United States, 2004-2005 influenza season. MMWR Morb
Mortal Wkly Rep 2006;55(38):1062-1065.
(9) http://www.cdc.gov/flu/protect/antiviral/ (Accessed August 1, 2007)
(10) Centers for Disease Control and Prevention. 2006. Active Bacterial
Core Surveillance Report, Emerging Infections
Program Network, Streptococcus pneumoniae, 2005. Available via the
(11) Medicare pays 95% of the Average Wholesale Price for influenza and
pneumococcal vaccine. The administration fee is priced according to the
physician fee schedule and varies by locality.
Contact: Jennifer Corrigan
732-742-7148 (Cell phone)
718-413-6491 (Cell phone)
SOURCE National Foundation for Infectious Diseases